Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Chemoprevention in FAP
NCT01725490Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Feb 2013
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in familial adenomatous polyposis (FAP), colorectal cancer (CRC), sponsored by Yonsei University. Started Feb 2013; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
familial adenomatous polyposis (FAP)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01725490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725490.